Reuters: Regulatory News: BRIEF-AstraZeneca, Bristol resubmit dapagliflozin in U.S.

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-AstraZeneca, Bristol resubmit dapagliflozin in U.S. Jul 25th 2013, 11:42 July 25 | Thu Jul 25, 2013 7:42am EDT July 25 (Reuters) - AstraZeneca PLC : * Astrazeneca Plc and Bristol-Myers Squibb Co say resubmit dapagliflozin new drug application in the U.S.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions